Literature DB >> 18727845

Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis.

R F Brown1, E M Valpiani, C C Tennant, S M Dunn, M Sharrock, S Hodgkinson, J D Pollard.   

Abstract

OBJECTIVES: No longitudinal studies have concurrently evaluated predictors of anxiety, depression, and fatigue in people with multiple sclerosis (PwMS). This study determined factors that best predicted anxiety, depression, and fatigue in MS patients from a large pool of disease, cognitive, life-event stressor (LES), psychosocial, life-style, and demographic factors.
DESIGN: A 2-year prospective longitudinal study evaluated predictors of psychological distress and fatigue in PwMS.
METHODS: One hundred and one consecutive participants with MS were recruited from two MS clinics in Sydney, Australia. LES, anxiety, depression, and fatigue were assessed at baseline and at 3-monthly intervals for 2-years. Disease, cognitive, demographic, psychosocial, and life-style factors were assessed at baseline. Patient-reported relapses were recorded and corroborated by neurologists or evaluated against accepted relapse criteria.
RESULTS: Depression strongly predicted anxiety and fatigue, and anxiety and fatigue strongly predicted later depression. Psychological distress (i.e. anxiety, depression) was also predicted by a combination of unhealthy behaviours (e.g. drug use, smoking, no exercise, or relaxation) and psychological factors (e.g. low optimism, avoidance coping), similar to the results of community-based studies. However, state-anxiety and fatigue were also predicted by immunotherapy status, and fatigue was also predicted by LES and demographics.
CONCLUSIONS: These results suggest that similar factors might underpin psychological distress and fatigue in MS patients and community-well samples, although MS treatment factors may also be important. These results might assist clinicians in determining which MS patients are at greatest risk of developing anxiety, depression, or fatigue.

Entities:  

Mesh:

Year:  2008        PMID: 18727845     DOI: 10.1348/147608308X345614

Source DB:  PubMed          Journal:  Psychol Psychother        ISSN: 1476-0835            Impact factor:   3.915


  29 in total

Review 1.  [Sleep disorders in neurological diseases].

Authors:  S Kotterba
Journal:  Nervenarzt       Date:  2015-06       Impact factor: 1.214

2.  Type D, anxiety and depression in association with quality of life in patients with Parkinson's disease and patients with multiple sclerosis.

Authors:  Tatiana Dubayova; Martina Krokavcova; Iveta Nagyova; Jaroslav Rosenberger; Zuzana Gdovinova; Berrie Middel; Johan W Groothoff; Jitse P van Dijk
Journal:  Qual Life Res       Date:  2012-10-11       Impact factor: 4.147

Review 3.  Psychiatric disorders in multiple sclerosis.

Authors:  Maddalena Sparaco; Luigi Lavorgna; Simona Bonavita
Journal:  J Neurol       Date:  2019-06-13       Impact factor: 4.849

Review 4.  Mental Health Comorbidity in MS: Depression, Anxiety, and Bipolar Disorder.

Authors:  Aaron P Turner; Kevin N Alschuler; Abbey J Hughes; Meghan Beier; Jodie K Haselkorn; Alicia P Sloan; Dawn M Ehde
Journal:  Curr Neurol Neurosci Rep       Date:  2016-12       Impact factor: 5.081

5.  Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice.

Authors:  João Carlos Correia de Sa; Laura Airas; Emmanuel Bartholome; Nikolaos Grigoriadis; Heinrich Mattle; Celia Oreja-Guevara; Jonathan O'Riordan; Finn Sellebjerg; Bruno Stankoff; Karl Vass; Agata Walczak; Heinz Wiendl; Bernd C Kieseier
Journal:  Ther Adv Neurol Disord       Date:  2011-05       Impact factor: 6.570

6.  Impact of psychotherapy on insomnia symptoms in patients with depression and multiple sclerosis.

Authors:  Kelly Glazer Baron; Marya Corden; Ling Jin; David C Mohr
Journal:  J Behav Med       Date:  2010-08-31

7.  Prevalence and predictors of depression in Iranian patients with multiple sclerosis: a population-based study.

Authors:  Seyed Mohammad Seyed Saadat; Mozaffar Hosseininezhad; Babak Bakhshayesh; Seyedeh Nastaran Seyed Saadat; Seyedeh Parand Nabizadeh
Journal:  Neurol Sci       Date:  2013-12-10       Impact factor: 3.307

8.  Fatigue and Comorbidities in Multiple Sclerosis.

Authors:  Kirsten M Fiest; John D Fisk; Scott B Patten; Helen Tremlett; Christina Wolfson; Sharon Warren; Kyla A McKay; Lindsay I Berrigan; Ruth Ann Marrie
Journal:  Int J MS Care       Date:  2016 Mar-Apr

9.  Prospective examination of anxiety and depression before and during confirmed and pseudoexacerbations in patients with multiple sclerosis.

Authors:  Michelle Nicole Burns; Ewa Nawacki; Juned Siddique; Daniel Pelletier; David C Mohr
Journal:  Psychosom Med       Date:  2012-11-28       Impact factor: 4.312

10.  Effectiveness of Fatigue Management Interventions in Reducing Severity and Impact of Fatigue in People with Progressive Multiple Sclerosis: A Systematic Review.

Authors:  Scott Rooney; Fiona Moffat; Les Wood; Lorna Paul
Journal:  Int J MS Care       Date:  2019 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.